Performance Disclosure - Jishi Media reported a net loss of 232 million yuan in the first half of 2025, with operating revenue of 999.7 million yuan, an increase of 8.7% year-on-year, compared to a net loss of 195 million yuan in the same period last year [1] - Sinopec's operating revenue for the first half of 2025 was 1.41 trillion yuan, a decrease of 10.6% year-on-year, with a net profit attributable to shareholders of 21.483 billion yuan, down 39.8% year-on-year [2] - Baofeng Energy achieved operating revenue of 22.82 billion yuan in the first half of 2025, an increase of 35.05% year-on-year, with a net profit attributable to shareholders of 5.718 billion yuan, up 73.02% year-on-year [3] Shareholding Changes - Zhongyin Securities announced that Jiangxi Copper intends to reduce its stake by no more than 8.334 million shares, representing up to 3% of the company's total share capital [4] - Boji Pharmaceutical's controlling shareholder Wang Tingchun and his concerted parties plan to reduce their holdings by no more than 1.14865 million shares, also up to 3% of the company's total share capital, between September 12, 2025, and December 11, 2025 [5] - Green Island Wind's shareholder, Zhenzhong Investment, intends to reduce its stake by no more than 680,000 shares, which is up to 1% of the company's total share capital [6] Risk Matters - Dameng Data announced that its director and senior vice president Chen Wen is under investigation, but the company's daily operations remain normal and business is progressing steadily [7]

Core Viewpoint - On August 21, several A-share listed companies disclosed their shareholding changes, with Yinzuo Co. announcing a plan to increase its stake, while ten other companies, including Guomai Technology and Zhen Shitong, revealed plans to reduce their holdings [1][2]. Group 1: Shareholding Increase - Yinzuo Co.'s controlling shareholder intends to increase their stake by 1%-2% [2]. Group 2: Shareholding Decrease - Guomai Technology plans to sell 1.54% of its repurchased shares [2]. - Zhen Shitong's shareholders plan to reduce their holdings by up to 3% [2]. - Jibite's vice chairman Chen Tuolin intends to reduce his stake by no more than 0.347% [2]. - Hongte Technology's shareholder Wu Xiaomin plans to decrease his holdings by up to 1% [2]. - Tongfei Co.'s shareholder Zhonghe Ying plans to reduce holdings by up to 764,400 shares [2]. - Boji Medical's controlling shareholder Gan Qinchun and his concerted parties plan to reduce their holdings by up to 3% [2]. - Lvdiaofeng's shareholder Zhenzhong Investment plans to decrease holdings by up to 1% [2]. - Tanjing's major shareholder Gan Jing plans to reduce his stake by up to 0.5% [2]. - Zhongyin Securities' Jiangxi Copper intends to reduce its holdings by no more than 3% [2]. - Hengbang Co. plans to opportunistically reduce its stake by up to 3.69% of its total share capital [2].

Group 1 - Shandong Commercial Group Co., Ltd., the controlling shareholder of Yinzuo Co., plans to increase its stake in the company by 1%-2% [1] - Hengbang Co. intends to reduce its holdings in Wanguo Gold by no more than 3.69% of its total share capital [1] - The controlling shareholder's concerted action partner of Zhen Shitong, Suzhou Longyue, plans to reduce its stake by no more than 3% [1] Group 2 - Jiang Copper Co., a shareholder of Zhongyin Securities, plans to reduce its stake by no more than 3% [1] - The controlling shareholder and its concerted action partners of Boji Pharmaceutical plan to reduce their holdings by no more than 3% [1] - Zhizhong Investment, a shareholder of Green Island Wind, plans to reduce its stake by no more than 1% [1] Group 3 - Wu Xiaomin, a shareholder of Hongte Technology, plans to reduce his stake by no more than 1% [1] - Wang Jing, the major shareholder of Tanjia, plans to reduce his stake by no more than 0.5% [1] - Zhonghe Ying, a shareholder of Tongfei Co., plans to reduce its stake by no more than 0.4503% [1] Group 4 - Chen Tuolin, the vice chairman of Jibite, plans to reduce his stake by no more than 0.3470% [1]

格隆汇8月21日丨博济医药(300404.SZ)公布，持有公司股份118,674,370股(占公司剔除回购专用证券账户 中股份数量后的总股本比例30.99%)的控股股东、实际控制人王廷春先生及持有公司股份5,536,700股(占 公司剔除回购专用证券账户中股份数量后的总股本比例1.45%)的一致行动人横琴广金美好基金管理有限 公司－广金美好费米十三号私募证券投资基金(简称"费米十三号")计划在公告披露之日起15个交易日后 的3个月内，以大宗交易或集中竞价的方式合计减持公司股份不超过11,486,500股(占公司剔除回购专用 证券账户中股份数量后的总股本比例的3.00%)。 ...

Buyback and Shareholder Actions - Sinopec plans to repurchase A-shares with a total fund of no less than RMB 5 billion and no more than RMB 10 billion, potentially reducing its registered capital [1] - Hengbang Mining intends to reduce its stake in the Hong Kong-listed company, WanGuo Gold, by up to 40 million shares, representing approximately 3.69% of WanGuo's total share capital [5] Product Approvals and Market Launches - Wantai Biological's nine-valent HPV vaccine has received the batch release certificate, marking its official market launch and enhancing the company's product lineup [1] - Changchun High-tech's subsidiary has received acceptance for the clinical trial application of GenSci143, a dual-specific antibody drug, which may provide new treatment options for certain tumors [7] Financial Performance - Hongxin Electronics reported a 15.01% increase in revenue to RMB 3.494 billion and a 9.85% rise in net profit to RMB 53.99 million for the first half of 2025 [2] - Sanwei Xinan experienced a net loss of RMB 29.39 million in the first half of 2025, despite a 15.19% increase in revenue to RMB 195 million [3] Corporate Developments - TianTan Bio received a commitment from its controlling shareholder to resolve new competition issues arising from a recent acquisition [4] - Feilu Co. announced a potential change in control, leading to a temporary suspension of its stock trading [8] Investment and Expansion - Jinbei Electric's subsidiary has signed a purchase agreement for a factory in Europe, marking significant progress in establishing its European production base [1] - Shengshi Technology plans to establish a wholly-owned subsidiary to integrate AI and humanoid robot technology with innovative toy products, investing RMB 10 million [6]

Group 1 - The core revenue composition of Boji Pharmaceutical for the year 2024 is 99.39% from services and 0.61% from sales [1] - The controlling shareholder, Wang Tingchun, holds approximately 119 million shares, representing 30.99% of the total share capital after excluding repurchased shares [3] - The company plans to reduce its shares by up to approximately 11.49 million shares, which is 3% of the total share capital after excluding repurchased shares, through block trading or centralized bidding within three months [3]

业绩披露 每经记者｜陈晴 每经编辑｜文多 博济医药：控股股东及其一致行动人拟减持不超公司3%的股份 博济医药公告，控股股东王廷春及一致行动人拟于2025年9月12日至2025年12月11日，通过大宗交易或 集中竞价合计减持不超过1148.65万股公司股份，即不超过公司总股本的3.00%。 吉视传媒：上半年净亏损2.32亿元 吉视传媒公告，2025年上半年营业收入为9.97亿元，同比增长8.70%，归母净利润为亏损2.32亿元，上 年同期公司净亏损1.95亿元。 中国石化：上半年归母净利润为214.83亿元 中国石化公告，2025年上半年营业收入为1.41万亿元，同比下降10.6%，归母净利润为214.83亿元，同 比下降39.8%。 宝丰能源：上半年归母净利润同比增长73.02% 宝丰能源公告，2025年上半年营业收入为228.20亿元，同比增长35.05%，归母净利润为57.18亿元，同 比增长73.02%。 增减持 中银证券：江西铜业拟减持不超公司3%的股份 中银证券公告，截至公告披露日，股东江西铜业持有公司1.3亿股，占公司总股本的4.70%；因自身经营 发展需要，拟合计减持不超过8334万股，即不超公 ...

博济医药公告，持有公司股份118674370股（占公司剔除回购专用证券账户中股份数量后的总股本比例 30.99%）的控股股东、实际控制人王廷春及持有公司股份5536700股（占公司剔除回购专用证券账户中 股份数量后的总股本比例1.45%）的一致行动人横琴广金美好基金管理有限公司－广金美好费米十三号 私募证券投资基金，计划在本公告披露之日起15个交易日后的3个月内，以大宗交易或集中竞价的方式 合计减持本公司股份不超过11486500股（占公司剔除回购专用证券账户中股份数量后的总股本比例的 3.00%）。 (本文来自第一财经) ...

人民财讯8月21日电，博济医药（300404）8月21日晚间公告，控股股东、实际控制人王廷春及其一致行 动人横琴广金美好基金管理有限公司-广金美好费米十三号私募证券投资基金(简称"费米十三号")计划15 个交易日后的3个月内，以大宗交易或集中竞价的方式合计减持公司股份不超过1148.65万股(占公司剔 除回购专用证券账户中股份数量后的总股本比例的3.00%)。 ...

博济医药公告，控股股东王廷春及一致行动人费米十三号拟于2025年9月12日至2025年12月11日，通过 大宗交易或集中竞价合计减持不超过1148.65万股，比例3.00%。其中，费米十三号拟大宗交易减持 170.79万股、集中竞价减持382.88万股，王廷春拟大宗交易减持594.98万股。 ...